Cleared Traditional

K152183 - EXELINT SecureTouch Safety Hypodermic Needle

K152183 is an FDA 510(k) clearance for EXELINT SecureTouch Safety Hypodermic N..., manufactured by Exelint International, Co.. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 89-day FDA review.

K152183 · Exelint International, Co. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2015
Decision
89d
Days
Class 2
Risk

K152183 is an FDA 510(k) clearance for the EXELINT SecureTouch Safety Hypodermic Needle. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Exelint International, Co. (Redondo Beach, US). The FDA issued a Cleared decision on November 2, 2015 after a review of 89 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Exelint International, Co. devices

FDA 510(k) Submission Details - K152183

510(k) Number K152183 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 05, 2015
Decision Date November 02, 2015
Days to Decision 89 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 129d · This submission: 89d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 534
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K152183.
Safe Block Pen Needle
K151311 · Artsana S.P.A · Feb 2016
Top Fine Pen Needle
K152410 · Medexel Co.,Ltd · Feb 2016
Clickfine AutoProtect Pen Needle
K152514 · Ypsomed AG · Nov 2015
Terumo SurGuard 3 Safety Hypodermic Needle
K152362 · Terumo (Philippines) Corporation · Oct 2015
Mini Needle
K151571 · Ocujet, LLC · Oct 2015
Turbo High-Flow Non-coring Needle
K151341 · Norfolk Medical · Aug 2015